Stockreport

Ultragenyx Pharmaceutical Inc (RARE) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... [Yahoo! Finance]

Ultragenyx Pharmaceutical Inc.  (RARE) 
Last ultragenyx pharmaceutical inc. earnings: 2/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ultragenyx.com/investor-relations
PDF 4 min read In This Article RARE Total Revenue (2024): $560 million, representing 29% growth over 2023. Crysvita Revenue (2024): $410 million, with 25% growth ov [Read more]